Furthermore, using anti-IL-1β blocking antibodies, chemotherapy induced IL-1β was shown to be required for the recruitment of IL-17-producing γδ T cells [87] and generation of IFN-γ-producing tumor-specific CD8 T cells [21]. The gene discussed is CD8A; the disease is neoplasm.